Table 2 Endoscopic stenting in bile duct injury patients. Short term complications and duration of treatment.
Cystic duct leakage n = 67 (%) | CBD leakage n = 26 (%) | CBD stricture n = 110 (%) | |
---|---|---|---|
Days between LC and referral, median (range) | 10 (1–40) | 15 (3–61) | 75 (4–2899) |
Maximum stents inserted during procedure, median (range) | 1 (1–3) | 1 (1–4) | 2 (1–7) |
Number of stent changes, median (range) | 2 (0–4) | 2 (1–5) | 4 (0–12) |
Number of patients with a stent related complication | 11 (16.4) | 1 (3.8) | 36 (32.7) |
Stent migration | 5 (7.5) | 0 | 21 (19.1) |
Clogging | 5 (7.5) | 1 (3.8) | 15 (13.6) |
Cholangitis | 1 (1.5) | 0 | 6 (5.5) |
Fausse route | 0 | 0 | 4 (3.6) |
Pain | 2 (3.0) | 0 | 18 (16.4) |
Total duration of stents in situ, months | |||
Mean (SD) | 1.7 (1.0) | 2.8 (3.0) | 11.5 (9.4) |
Median, (range) | 1.5 (0.4–7.8) | 1.8 (0.7–11.2) | 11 (1–69) |
BDI, bile duct injury; CBD, common bile duct; LC, laparoscopic cholecystectomy.